To Determine Bioequivalence Under Fasting Conditions Completed Phase 1 Trials for Buspirone (DB00490)

IndicationStatusPhase
DBCOND0039998 (To Determine Bioequivalence Under Fasting Conditions)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00653419Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions